Susquehanna International Group
TWST icon

Susquehanna International Group’s Twist Bioscience TWST Stock Holding History

Susquehanna International Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.29M Buy
90,319
+19,566
+28% +$877K ﹤0.01% 4522
2025
Q4 		$2.24M Buy
70,753
+53,798
+317% +$1.68M ﹤0.01% 5413
2025
Q3 		$477K Sell
16,955
-60,519
-78% -$1.83M ﹤0.01% 9066
2025
Q2 		$2.85M Sell
77,474
-6,391
-8% -$221K ﹤0.01% 5061
2025
Q1 		$3.29M Buy
83,865
+41,422
+98% +$1.87M ﹤0.01% 4471
2024
Q4 		$1.97M Buy
42,443
+9,609
+29% +$434K ﹤0.01% 5348
2024
Q3 		$1.48M Sell
32,834
-77,886
-70% -$3.71M ﹤0.01% 5933
2024
Q2 		$5.46M Buy
110,720
+92,041
+493% +$3.75M ﹤0.01% 3308
2024
Q1 		$641K Sell
18,679
-114,069
-86% -$4.12M ﹤0.01% 7914
2023
Q4 		$4.89M Buy
132,748
+55,627
+72% +$1.29M ﹤0.01% 3732
2023
Q3 		$1.56M Buy
77,121
+37,699
+96% +$828K ﹤0.01% 5642
2023
Q2 		$807K Sell
39,422
-116,717
-75% -$1.75M ﹤0.01% 7177
2023
Q1 		$2.35M Buy
156,139
+122,790
+368% +$2.71M ﹤0.01% 4801
2022
Q4 		$794K Sell
33,349
-41,263
-55% -$1.2M ﹤0.01% 6695
2022
Q3 		$2.63M Buy
74,612
+45,731
+158% +$1.94M ﹤0.01% 4349
2022
Q2 		$1.01M Sell
28,881
-12,442
-30% -$441K ﹤0.01% 6515
2022
Q1 		$2.04M Sell
41,323
-44,209
-52% -$2.45M ﹤0.01% 5431
2021
Q4 		$6.62M Buy
85,532
+51,797
+154% +$5.32M ﹤0.01% 3299
2021
Q3 		$3.61M Buy
33,735
+4,515
+15% +$517K ﹤0.01% 4570
2021
Q2 		$3.89M Buy
29,220
+18,766
+180% +$2.18M ﹤0.01% 4495
2021
Q1 		$1.29M Sell
10,454
-41,687
-80% -$6.33M ﹤0.01% 7040
2020
Q4 		$7.37M Buy
52,141
+35,083
+206% +$3.89M ﹤0.01% 2876
2020
Q3 		$1.3M Sell
17,058
-5,886
-26% -$366K ﹤0.01% 5504
2020
Q2 		$1.04M Buy
22,944
+2,522
+12% +$90.5K ﹤0.01% 5835
2020
Q1 		$625K Buy
+20,422
New +$549K ﹤0.01% 6444
2019
Q4 		– Sell
-12,504
Closed -$299K – 10675
2019
Q3 		$299K Sell
12,504
-1,425
-10% -$41.4K ﹤0.01% 8311
2019
Q2 		$404K Buy
+13,929
New +$368K ﹤0.01% 7718

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's TWST Position: Q1 2026 in Review

Susquehanna International Group increased its Twist Bioscience (TWST) stake by 28% in Q1 2026, buying an estimated $877K and bringing the position to 90,319 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4522.

Susquehanna International Group first reported a position in TWST in Q2 2019 and has held it in 27 quarters since. The position peaked at $7.37M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Susquehanna International Group held 90,319 shares of Twist Bioscience worth $4.29M as of Q1 2026.
  • Susquehanna International Group bought 19,566 Twist Bioscience shares in Q1 2026, an estimated $877K.
  • Twist Bioscience made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4522 holding.
  • Susquehanna International Group first reported a position in Twist Bioscience in Q2 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Twist Bioscience position peaked at $7.37M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.